Debt Obligations (Additional Information) (Details) $ / shares in Units, shares in Thousands |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
|
Mar. 29, 2025
shares
|
Jun. 30, 2026
USD ($)
shares
Tradingday
$ / shares
|
Jun. 28, 2025
USD ($)
|
|
| Debt Instrument [Line Items] | |||
| Payments for Repurchase of Common Stock | $ 204,979,000 | $ 75,015,000 | |
| Stock Repurchased During Period, Shares | shares | 492 | (805) | |
| Debt Instrument, Convertible, Terms of Conversion Feature | Beginning on March 1, 2031 and until the close of business on the second Scheduled Trading Day (as defined in the Indenture) immediately before the maturity date, the 2031 Notes will be convertible at the option of the noteholders at any time. If holders convert, we will settle conversions by paying cash up to the aggregate principal amount of the 2031 Notes to be converted and paying or delivering, as the case may be, cash, shares, or a combination thereof, at our election, in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the 2031 Notes being converted. Any 2031 Notes that remain outstanding at maturity are required to be repaid in cash.Before March 1, 2031, noteholders will have the right to convert their 2031 Notes only under the following circumstances:(1)during any fiscal quarter (and only during such fiscal quarter) commencing after the fiscal quarter ending on September 30, 2026, if the Last Reported Sale Price (as defined in the Indenture) per share of Common Stock, exceeds 130% of the conversion price (as described below) for each of at least 20 Trading Days (as defined in the Indenture) (whether or not consecutive) during a period of 30 consecutive Trading Days ending on, and including, the last Trading Day of the immediately preceding fiscal quarter;(2)during the five consecutive business days immediately after any ten consecutive Trading Day period (the “Measurement Period”) in which the Trading Price (as defined in the Indenture) per $1,000 principal amount of 2031 Notes for each Trading Day of the Measurement Period was less than 98% of the product of the Last Reported Sale Price per share of the Common Stock on such Trading Day and the conversion rate (as described below) on each Trading Day;(3)upon the occurrence of specified corporate events or distributions on the Common Stock as set forth in the Indenture; or(4)if the Company calls such 2031 Notes for redemption. As of June 30, 2026, none of the foregoing conditions permitting early conversion of the 2031 Notes had been satisfied. Accordingly, the 2031 Notes were not convertible at the option of the noteholders as of such date, and the Company has classified the 2031 Notes as a non-current liability.The Company may not redeem the 2031 Notes at its option at any time before June 6, 2029. The Company will have the option to redeem the 2031 Notes, in whole or in part (subject to the partial redemption limitation set forth in the Indenture), at any time, and from time to time, on or after June 6, 2029 and before the 31st Scheduled Trading Day immediately before the maturity date, at a cash redemption price equal to the principal amount of the 2031 Notes to be redeemed, plus accrued and unpaid special interest and additional interest, if any, to, but excluding, the redemption date, but only if the Last Reported Sale Price per share of the Common Stock exceeds 130% of the conversion price on (1) each of at least 20 Trading Days, whether or not consecutive, during the 30 consecutive Trading Days ending on, and including, the Trading Day immediately before the date the Company sends the related redemption notice; and (2) the Trading Day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a Make-Whole Fundamental Change (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption. Pursuant to the partial redemption limitation, the Company may not elect to redeem less than all of the outstanding 2031 Notes unless at least $100.0 million aggregate principal amount of 2031 Notes are outstanding and not subject to redemption as of the time it sends the related redemption notice.The conversion rate for the 2031 Notes will initially be 2.6192 shares of Common Stock per $1,000 principal amount of 2031 Notes, which is equivalent to an initial conversion price of approximately $381.80 per share of Common Stock. The conversion rate is subject to adjustment upon certain events specified in the Indenture but will not be adjusted for any accrued or unpaid interest. In addition, upon a Make-Whole Fundamental Change, the Company will, under certain circumstances, increase the applicable conversion rate for a holder that elects to convert its 2031 Notes in connection with such Make-Whole Fundamental Change. No adjustment to the conversion rate will be made if the Stock Price (as defined in the Indenture) in such Make-Whole Fundamental Change is either less than $254.53 per share or greater than $2,750.00 per share. The Company will not increase the conversion rate to an amount that exceeds 3.9288 shares per $1,000 principal amount of 2031 Notes, subject to adjustment as set forth in the Indenture. Based on the initial conversion rate, the 2031 Notes are initially convertible into approximately 3.9 million shares of the Common Stock (based on an aggregate principal amount of $1.5 billion). Assuming the maximum conversion rate of 3.9288 shares per $1,000 principal amount in connection with a Make Whole Fundamental Change, the 2031 Notes would be convertible into a maximum of approximately 5.9 million shares of Common Stock, subject to adjustment as set forth in the Indenture. | ||
| Debt Instrument, Convertible, Conversion Price | $ / shares | $ 254.53 | ||
| Payments for (Proceeds from) Hedge, Financing Activities, Total | $ 88,900,000 | ||
| Deferred Tax Assets, Gross, Total | 19,300 | ||
| ConvertibleSeniorNotesDue2031Member | |||
| Debt Instrument [Line Items] | |||
| Debt Instrument, Face Amount | $ 1,500,000,000 | ||
| Debt Instrument, Description | option to purchase up to an additional $200 million aggregate principal amount of 2031 Notes | ||
| Proceeds from Issuance of Long-Term Debt, Total | $ 1,470,000,000 | ||
| Payments for Repurchase of Common Stock | $ 204,900,000 | ||
| Share Price | $ / shares | $ 254.53 | ||
| Debt Instrument, Interest Rate, Effective Percentage | 0.39% | ||
| Debt Instrument, Interest Rate Terms | 0.50% | ||
| Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 130.00% | ||
| Debt Instrument, Convertible, Threshold Trading Days | Tradingday | 20 | ||
| Debt Instrument, Convertible, Threshold Consecutive Trading Days | Tradingday | 30 | ||
| Debt Instrument, Covenant Description | If certain corporate events that constitute a Fundamental Change (as defined in the Indenture) occur, then, subject to certain exceptions, noteholders may require the Company to repurchase their 2031 Notes in whole or in part for cash at a price equal to the principal amount of the 2031 Notes to be repurchased, plus accrued and unpaid special interest and additional interest, if any, to, but excluding, the Fundamental Change Repurchase Date (as defined in the Indenture). The Indenture governing the 2031 Notes contains customary terms and covenants, including those limiting the Company’s ability to consolidate with or merge into, or sell, lease or otherwise transfer substantially all of its assets, as well as customary events of default, each as defined in the Indenture. | ||
| Debt, Policy [Policy Text Block] | The 2031 Notes are presented as “2031 Notes, net” within non-current liabilities on the condensed consolidated balance sheet as of June 30, 2026 and are carried at amortized cost. The Company evaluated the terms of the 2031 Notes under applicable accounting guidance and concluded that the 2031 Notes are appropriately accounted for as a single liability instrument, with no bifurcation or other separate accounting required. |
||
| Debt Instrument, Convertible, Conversion Price | $ / shares | $ 381.8 | ||
| Debt Instrument, Convertible, Conversion Ratio | 2.6192 | ||
| Debt Instrument, Convertible, Number of Equity Instruments | shares | 3,900 | ||
| Shares, Issued | shares | 3,900 | ||
| Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares | $ 509.06 | ||
| ConvertibleSeniorNotesDue2031Member | Capped Call Transactions [Member] | |||
| Debt Instrument [Line Items] | |||
| Payments for (Proceeds from) Derivative Instrument, Financing Activities, Total | $ 88,900,000 | ||
| Debt Instrument Convertible Conversion Premium Percentage Price | 100.00% | ||
| ConvertibleSeniorNotesDue2031Member | Trading Price Condition [Member] | |||
| Debt Instrument [Line Items] | |||
| Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | 98.00% | ||
| Debt Instrument, Convertible, Conversion Ratio | 3.9288 | ||
| Debt Instrument, Convertible, Number of Equity Instruments | shares | 5,900 | ||
| Bridge Loan [Member] | |||
| Debt Instrument [Line Items] | |||
| Line of Credit Facility, Maximum Borrowing Capacity | $ 500,000,000 | ||
| Debt Issuance Costs, Gross | 4,400,000 | ||
| Debt Instrument, Fee Amount | $ 3,750,000 | ||